Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedOct 22, 2014Propranolol HClcGMP Deviations: GYMA laboratories Inc. has recalled multiple Active Pharmaceutical Ingredients manufactured in Italy upon receipt of a Rapid Alert Notification issued...Gyma Laboratories Of Amer,Inc · D-0022-2015Class IITerminatedOct 22, 2014Dipyridamole APIcGMP Deviations: GYMA laboratories Inc. has recalled multiple Active Pharmaceutical Ingredients manufactured in Italy upon receipt of a Rapid Alert Notification issued...Gyma Laboratories Of Amer,Inc · D-0021-2015Class ITerminatedOct 22, 2014Lidocaine HCl InjectionPresence of Particulate Matter: The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial.Hospira Inc. · D-0020-2015Class IIITerminatedOct 22, 2014VasotecLabeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package insert.Valeant Pharmaceuticals North America LLC · D-0019-2015Class IIITerminatedOct 22, 2014VasereticLabeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outsetValeant Pharmaceuticals North America LLC · D-0018-2015Class IITerminatedOct 22, 2014Atorvastatin Calcium 40 MG TabletPresence of Foreign Tablets/Capsules:179 doses of Valacyclovir HCl 500 mg tablets were repacked in unit dose packslabeled as Atorvastatin CalciumUnit Dose Solutions Inc · D-0017-2015Class IITerminatedOct 22, 2014HYDROXYPROGESTERONE CAPROATE 250 MG/MLCrystallization: Formation of crystals observed in product.Avella of Deer Valley, Inc. · D-0016-2014Class IITerminatedOct 22, 2014TOPIRAMATE Tablets 200 mgPresence of Foreign Tablets: Presence of topiramate 100 mg tablets comingled with 200 mg tablets.Zydus Pharmaceuticals USA Inc · D-0015-2015Class IIITerminatedOct 15, 2014E-Z- GAS II EFFERVESCENT GRANULES Antacid/AntiflatulentSubpotent Drug: Out of Specification (OOS) result during routine stability testing at 24 months.Bracco Diagnostic Inc · D-0014-2015Class IIITerminatedOct 15, 2014TruvadaPresence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.Gilead Sciences, Inc. · D-0013-2015Class IITerminatedOct 15, 2014All sterile products within expiryLack of Sterility Assurance: A recent FDA inspection revealed poor aseptic production practices that result in lack of sterility assurance of products intended to be...Unique Pharmaceutical, Ltd · D-0012-2015Class ITerminatedOct 15, 2014N-Acetyl Cysteine 20% 4 mL Vial Stock Code: 4133Non-Sterility: One lot of N-Acetyl Cysteine vials tested positive for Herbaspirillum huttiense.Unique Pharmaceutical, Ltd · D-0011-2015Class IITerminatedOct 15, 2014METOCLOPRAMIDE ORAL SOLUTIONDefective Container: Product leaks when inverted.VistaPharm, Inc. · D-0010-2015Class IITerminatedOct 15, 2014Metoprolol Succinate Extended-release TabletsPresence of Foreign Tablets/Capsules: A pharmacist reported a rogue tablet of different size and markings in bottle of MetoprololMylan Pharmaceuticals Inc. · D-0009-2015Class IITerminatedOct 15, 2014TarcevaFailed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.Astellas Pharma US Inc · D-0008-2015Class IITerminatedOct 15, 2014ZyGenerics ATENOLOL TabletsSuperpotent Drug: A complaint was reported by a pharmacist who stated several tablets were noticeably thicker in appearance.Zydus Pharmaceuticals USA Inc · D-0007-2015Class IITerminatedOct 15, 2014XareltoMicrobial Contamination of Non-Sterile Products: Consumer complaint confirmed microbial contamination in sales sample.Janssen Ortho L.L.C. · D-0006-2015Class IITerminatedOct 15, 2014Amiodarone HCl InjectionTemperature Abuse: One shipment was inadvertantly stored refrigerated rather than the labeled room temperature recommendation at McKesson Medical-Surgical Inc., one of...Mckesson · D-0005-2015Class ITerminatedOct 8, 2014AFRICAN BLACK ANTMarketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.Eugene Oregon, Inc. · D1612-2014Class IITerminatedOct 8, 2014Diclofenac Sodium and Misoprostol Delayed-Release TabletsFailed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.Actavis Laboratories, FL, Inc. · D-1617-2014Class IITerminatedOct 8, 2014Diclofenac Sodium and Misoprostol Delayed-Release TabletsFailed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.Actavis Laboratories, FL, Inc. · D-1616-2014Class IITerminatedOct 8, 2014Zoledronic Acid Injection 5 mg per 100 mLLack of Assurance of Sterility; leaking of premix bagsSagent Pharmaceuticals Inc · D-1615-2014Class ITerminatedOct 8, 2014MOJO RISENMarketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.Eugene Oregon, Inc. · D-1614-2014Class ITerminatedOct 8, 2014Black AntMarketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.Eugene Oregon, Inc. · D-1613-2014Class IITerminatedOct 8, 2014CREON (pancrelipase) Delayed-Release CapsulesPresence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.AbbVie Inc · D-1611-2014Class ITerminatedOct 8, 2014Dianeal Low CalciumPresence of Particulate Matter: particulate matter was found during the manufacturing process.Baxter Healthcare Corp. · D-1610-2014Class IITerminatedOct 8, 2014DOPamine Hydrochloride and 5% Dextrose INJLack of Assurance of Sterility: A small cut in the solution bag may have been introduced during the manufacturing process, resulting in a leak of the bag into the...Baxter Healthcare Corp. · D-0004-2015Class IITerminatedOct 8, 2014All sterile drugs compounded between 2/21/14 and 2/24/14Lack of Assurance of Sterility: All compounded products.New England Home Therapies, Inc · D-0003-2015Class ITerminatedOct 8, 2014MarcainePresence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.Hospira Inc. · D-0002-2015Class ITerminatedOct 8, 2014CUBICINPresence of Particulate Matter: Potential presence of glass particulate matter in the vials.Cubist Pharmaceuticals, Inc. · D-0001-2015Class IIITerminatedOct 1, 2014Olanzapine Orally Disintegrating Tablets 5 mgSubpotent Drug: Out of specification (OOS) results at the 9 month temperature point.Apotex Corp. · D-1609-2014Class IITerminatedOct 1, 2014DaytranaDefective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver...Noven Pharmaceuticals, Inc. · D-1608-2014Class IITerminatedOct 1, 2014Oxycodone and Acetaminophen Tablets USP 10 mg/325 mgFailed Content Uniformity Specifications - The lot failed to meet the acceptance criteria for Uniformity of Dosage Units at the time of release for the oxycodone...Alvogen, Inc · D-1607-2014Class IITerminatedOct 1, 2014Potassium Chloride InjectionCorrect Labeled Product Mispack: Shipping cartons labeled as containing Potassium Chloride injection actually contained bags labeled and containing Gentamicin Sulfate...Baxter Healthcare Corp · D-1606-2014Class IIITerminatedOct 1, 2014MethylPREDNISolone TABLETSSubpotent; 6 month stability time pointQualitest Pharmaceuticals · D-1605-2014Class IITerminatedOct 1, 2014Buprenorphine Hydrochloride InjectionFailed Impurities/Degradation Specification: Out of Specification results for pseudobuprenorphine impurity at the 9-month stability time point.Hospira Inc. · D-1604-2014Class IIITerminatedOct 1, 2014Rifampin for Injection USPFailed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time pointAkorn, Inc. · D-1571-2014Class ITerminatedSep 24, 2014MOJO RISENMarketed Without an Approved NDA/ANDA; Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling AFRICAN BLACK ANT because FDA laboratory analysis determined...Nova Products, Inc. · D-1603-2014Class ITerminatedSep 24, 2014XZONE GOLDMarketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling XZONE GOLD because FDA laboratory analysis determined that...Nova Products, Inc. · D-1602-2014Class ITerminatedSep 24, 2014Xzone 1200Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling XZone 1200because FDA laboratory analysis determined that they...Nova Products, Inc. · D-1601-2014

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.